CEO of RespireRX Pharmaceuticals Inc., Tim Jones, is Featured on The Stock Day Podcast

The Stock Day Podcast welcomed RespireRX Pharmaceuticals Inc. (RSPI)(“the Company”), a leader in the development of medicines for respiratory disorders and CNS indications, with a focus on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury and other neurological conditions. CEO of the Company, Tim Jones, joined Stock Day host Everett Jolly.

READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/ceo-of-respirerx-pharmaceuticals-inc-tim-jones-is-featured-on-the-stock-day-podcast-rspi-august-17-2020/